Kazia Therapeutics-Spon ADRKZIA
13F holders, Q1 2026 (March 31)23holders +1
7new positions
6sold out
1famous investor
$7.44avg. 13F price*
At the end of Q1 2026, 23 institutions reported holding Kazia Therapeutics-Spon ADR (KZIA) in their 13F filings, up 1 from Q4 2025. 7 opened new positions and 6 sold out. The largest holders were Bleichroeder LP ($3.0M), Stonepine Capital Management, LLC ($2.6M) and Point72 Asset Management ($1.5M). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Kazia Therapeutics-Spon ADR
- CUSIP
- 48669G303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $3.2M |
| Exits | 6 | $6.8M |
All 13F filers, Q4 2025 → Q1 2026: 563,113 shares bought and 1,288,731 shares sold, net −725,618 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Bleichroeder LP | 0.51% | No change | 400,000 | $3.0M |
| Stonepine Capital Management, LLC | 2.26% | Reduce -25.0% | 345,179 | $2.6M |
| Point72 Asset Management | 0.00% | No change | 200,000 | $1.5M |
| Balyasny Asset Management L.P. | 0.00% | New | 193,114 | $1.4M |
| Flputnam Investment Management Co. | 0.02% | New | 142,469 | $1.1M |
| Velan Capital Investment Management LP | 0.63% | Reduce -54.9% | 135,315 | $1.0M |
| Dauntless Investment Group, LLC | 1.67% | Add +7983100.0% | 79,832 | $594K |
| Sequoia Financial Advisors, LLC | 0.00% | New | 60,000 | $446K |
| Westside Investment Management, Inc. | 0.06% | Add +63.3% | 50,425 | $375K |
| Royal Bank of Canada | 0.00% | Reduce -36.6% | 34,340 | $255K |
| Barclays PLC | 0.00% | No change | 23,999 | $179K |
| Raymond James Financial Inc. | 0.00% | New | 15,749 | $117K |
| UBS Group AG | 0.00% | Add +7119.7% | 13,934 | $104K |
| Rockefeller Capital Management L.P. | 0.00% | Add +18.7% | 12,700 | $94K |
| Laird Norton Wetherby Trust Company, LLC | 0.00% | New | 12,400 | $92K |
| Qube Research & Technologies Ltd | 0.00% | New | 10,608 | $79K |
| FNY Investment Advisers, LLC | 0.03% | Add +33.3% | 10,000 | $74K |
| Osaic Holdings, Inc. | 0.00% | Add +87340.0% | 8,744 | $65K |
| GAMMA Investing LLC | 0.00% | Add +575.9% | 1,568 | $12K |
| Rhumbline Advisers | 0.00% | Reduce -10.4% | 1,402 | $10K |
| BNP Paribas Financial Markets | 0.00% | New | 1,081 | $8K |
| Morgan Stanley | 0.00% | No change | 1,000 | $7K |
| Allworth Financial LP | 0.00% | No change | 1 | $8 |
"% of holder's portfolio" is KZIA's weight in each manager's 13F, not the share of Kazia Therapeutics-Spon ADR the manager owns.